Methanosarcinaceae

From WikiMD's WELLNESSPEDIA

Methanosarcina barkeri

The Methanosarcinaceae are a family of archaea within the order Methanosarcinales. These microorganisms are known for their ability to produce methane as a metabolic byproduct in anoxic conditions. They are a significant group within the methanogens, which are a type of anaerobic microorganism that play a crucial role in the carbon cycle.

Characteristics[edit]

Members of the Methanosarcinaceae family are characterized by their ability to utilize a wide range of substrates for methanogenesis, including acetate, methanol, and methylamines. This versatility distinguishes them from other methanogens that typically rely on a more limited set of substrates. The ability to use acetate is particularly important in environments such as wetlands, landfills, and the digestive tracts of ruminants, where acetate is a common intermediate.

Morphology[edit]

Methanosarcinaceae are typically coccoid in shape, although some species can form aggregates or filaments. The cell walls of these archaea are composed of pseudopeptidoglycan, which is distinct from the peptidoglycan found in bacteria. This structural difference is one of the key features that differentiate archaea from bacteria.

Habitat[edit]

These archaea are found in a variety of anaerobic environments, including marine and freshwater sediments, sewage sludge, and the gastrointestinal tracts of animals. Their ability to thrive in diverse environments is due to their metabolic flexibility and their ability to form biofilms, which can protect them from environmental stresses.

Methanogenesis[edit]

Methanogenesis in Methanosarcinaceae involves the reduction of carbon compounds to methane. This process is a form of anaerobic respiration and is crucial for the recycling of carbon in anaerobic environments. The pathway of methanogenesis in these archaea involves unique coenzymes and enzymes, such as coenzyme M and methyl-coenzyme M reductase.

Related pages[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.